Regulated information
Ghent - 5 April 2012
In accordance with Article 15 §1 of the Act of 2 May 2007 on
the disclosure of major shareholdings, Devgen nv today
announces the issuance of 11,479 common shares by the Company
as the result of the exercise of warrants. As a result of
this transaction, Devgen now has 24,277,879 shares
outstanding.
Total share capital (EUR) | 1,820,838.61 |
Total number of securities conferring voting rights | 24,277,879 |
Total number of voting rights (the denominator): | 24,277,879 |
Total number of securities conferring voting rights by category: | N/A |
Total number of voting rights by category | N/A |
Total number of convertible bonds conferring voting rights | none |
Total number of rights, materialized by certificates or not, to subscribe to not yet issued securities which confer voting rights | 1,597,406 warrants |
Total number of voting rights which result from the exercise of these conversion or subscription rights | 1,597,406 |
Total number of shares without voting rights | none |
Devgen's mission is to shape the field of hybrid rice in
India and Southeast Asia and help farmers meet the
productivity increases needed to grow more food on less land
using less water, labour and agro-chemicals.
Devgen uses advanced biotechnology and molecular breeding
technology to develop the Next Generation Hybrid Rice
(NGHRTM) seeds and crop protection solutions
with a superior environmental profile: